Piedmont Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-32,048
Closed -$2.16M 199
2020
Q1
$2.16M Buy
32,048
+4,952
+18% +$308K 0.09% 198
2019
Q4
$1.48M Buy
27,096
+136
+0.5% +$6.45K 0.05% 248
2019
Q3
$1.01M Buy
26,960
+268
+1% +$10.4K 0.04% 316
2019
Q2
$1M Buy
26,692
+1,228
+5% +$38.6K 0.04% 327
2019
Q1
$758K Buy
25,464
+80
+0.3% +$2.81K 0.03% 367
2018
Q4
$760K Buy
25,384
+96
+0.4% +$3.04K 0.04% 327
2018
Q3
$904K Buy
+25,288
New +$784K 0.04% 322

Other funds holding DXCM

Piedmont Investment Advisors's DXCM Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of DexCom (DXCM) in Q2 2020, closing a stake of 32,048 shares — an estimated $2.16M sold.

Piedmont Investment Advisors first reported a position in DXCM in Q3 2018 and held it in 7 quarters. The position peaked at $2.16M in Q1 2020. 722 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining DexCom position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 32,048 DexCom shares in Q2 2020, an estimated $2.16M.
  • Piedmont Investment Advisors first reported a position in DexCom in Q3 2018 and held it in 7 quarters.
  • Piedmont Investment Advisors's DexCom position peaked at $2.16M in Q1 2020.
  • 722 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.